Physician profile
Marisol Llamera
NPI 1073982021
$1,447.87
in general payments reported to CMS, 2019-2025
19 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $527 · 2022: $392 · 2023: $267 · 2024: $90.66 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $260.48 | 2021-2024 | Spravato, Xarelto |
| Boston Scientific Corporation | $256.37 | 2021-2025 | Watchman Flx, Epic Vascular |
| Galderma Laboratories, L.P. | $256.20 | 2022 | |
| Neurocrine Biosciences, INC. | $111.63 | 2025 | |
| Abbott Laboratories | $108.37 | 2021 | |
| Merck Sharp & Dohme LLC | $49.29 | 2021-2022 | |
| Angiodynamics, INC. | $45.59 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $44.80 | 2021-2023 | Uptravi |
| Edwards Lifesciences Corporation | $43.03 | 2023 | |
| Kestra Medical Technology Services, INC. | $40.31 | 2023 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $33.97 | 2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $33.00 | 2021 | |
| Becton, Dickinson and Company | $32.03 | 2024 | Crosser Iq |
| Astrazeneca Pharmaceuticals LP | $28.32 | 2021 | |
| Alnylam Pharmaceuticals INC. | $26.96 | 2023 | Onpattro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $23.05 | 2024 | |
| Cardiva Medical, INC. | $21.01 | 2025 | Optowire |
| Novo Nordisk INC | $18.24 | 2025 | Wegovy |
| Sun Pharmaceutical Industries INC. | $15.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisol Llamera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.